Skip to content

With pressure to get products to market and meet corporate targets, it’s understandable that the returns and destruction elements of clinical trials are often something of an afterthought.

At Sharp, we proactively encourage our clients to plan ahead and create an outline plan for how returns, reconciliation and destruction will be managed during the set-up phase of the project. It’s the best way to make sure the process is handled as efficiently and cost-effectively as possible.

Our experts can help you plan ahead, so when your trial comes to an end you can focus on moving forward, knowing it’s all is taken care of. If you’re there already and need some extra support now, we also have well-established procedures that can be rolled out to any study at short notice.

Our services include:

  • Customer and project-specific returns and reconciliation protocols
  • Ample, dedicated returns storage
  • Regulatory compliance and documentation support
  • Reconciliation services
  • Hazardous and non-hazardous destruction
  • Updated and complete documentation on destruction
  • Issuing of certificates of destruction

Related Resources

Our team based in Rhymney, South Wales is looking for a #ProposalsWriter to work closely with the business development teams in the preparation of proposals for new business.

Click here to learn more and to apply: https://lnkd.in/dEje_-kS

#OurWorkMatters

We are pleased to announce that the @AlliancetoZero has won the Environmental Impact award presented by the Pharmaceutical Technology Excellence Awards.

Click the link to download the digital awards report: https://lnkd.in/dnZ46vXA

#sustainability #netzero #climateaction #pharma

In this blog, Ria Rhemrev-Boom, lead EU QP for Sharp, comments on how the role of a QP has changed over time and reveals how Sharp has adapted to manage the increased burden assigned to QPs.

Click here to read the full blog: https://lnkd.in/dYi_rkjp